Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine pathology: JAMA
Researchers have discovered in a new cohort study of women with benign uterine pathology or endometrial hyperplasia (EH) that the combination of a glucagon-like peptide-1 receptor agonist (GLP-1RAs) and progestin…